Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v8-FR
Language French French
Date Updated 2024-01-25 2024-01-08
Drug Identification Number 02456753 02456753
Brand name TEVA-DULOXETINE TEVA-DULOXETINE
Common or Proper name TEVA-DULOXETINE HCL 30MG CAPS TEVA-DULOXETINE HCL 30MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DULOXETINE DULOXETINE
Strength(s) 30MG 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-09 2023-09-09
Estimated end date 2024-02-29 2024-02-29
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments